Aloe vera supplementation improves cardiovascular risk factors in hemodialysis patients: A randomized, double-blind, placebo-controlled trial

Kooshki, A., Memarzadeh, M. R., Rakhshani, M. H., Akbarzadeh, R., Tofighiyan, T., Foroumandi, E. (2023). 'Aloe vera supplementation improves cardiovascular risk factors in hemodialysis patients: A randomized, double-blind, placebo-controlled trial', Avicenna Journal of Phytomedicine, (), pp. -. doi: 10.22038/ajp.2023.23447

留言 (0)

沒有登入
gif